These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34827559)

  • 21. P2X7 receptor antagonism by AZ10606120 significantly depletes glioblastoma cancer stem cells in vitro.
    Kan LK; Drill M; Jayakrishnan PC; Sequeira RP; Sanfilippo PG; McLean C; Hunn M; Williams DA; O'Brien TJ; Drummond KJ; Monif M
    Brain Res Bull; 2024 Sep; 215():110996. PubMed ID: 38857832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells.
    Zhao K; Schäfer A; Zhang Z; Elsässer K; Culmsee C; Zhong L; Pagenstecher A; Nimsky C; Bartsch JW
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.
    Tentori L; Ricci-Vitiani L; Muzi A; Ciccarone F; Pelacchi F; Calabrese R; Runci D; Pallini R; Caiafa P; Graziani G
    BMC Cancer; 2014 Mar; 14():151. PubMed ID: 24593254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to Temozolomide.
    Nakagawa-Saito Y; Mitobe Y; Togashi K; Suzuki S; Sugai A; Kitanaka C; Okada M
    Anticancer Res; 2023 Mar; 43(3):1131-1138. PubMed ID: 36854532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma.
    Eckert M; Klumpp L; Huber SM
    Cell Physiol Biochem; 2017; 44(4):1591-1605. PubMed ID: 29212069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
    Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
    Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage.
    Paranjpe A; Zhang R; Ali-Osman F; Bobustuc GC; Srivenugopal KS
    Carcinogenesis; 2014 Mar; 35(3):692-702. PubMed ID: 24193513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model.
    Serra R; Zhao T; Huq S; Gorelick NL; Casaos J; Cecia A; Mangraviti A; Eberhart C; Bai R; Olivi A; Brem H; Jackson EM; Tyler B
    PLoS One; 2021; 16(11):e0251957. PubMed ID: 34731160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation.
    Wang K; Michelakos T; Wang B; Shang Z; DeLeo AB; Duan Z; Hornicek FJ; Schwab JH; Wang X
    Cancer Lett; 2021 May; 505():37-48. PubMed ID: 33582212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram.
    Cong J; Wang Y; Zhang X; Zhang N; Liu L; Soukup K; Michelakos T; Hong T; DeLeo A; Cai L; Sabbatino F; Ferrone S; Lee H; Levina V; Fuchs B; Tanabe K; Lillemoe K; Ferrone C; Wang X
    Cancer Lett; 2017 Nov; 409():9-19. PubMed ID: 28864067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.
    Noh H; Zhao Q; Yan J; Kong LY; Gabrusiewicz K; Hong S; Xia X; Heimberger AB; Li S
    Cancer Lett; 2018 Oct; 433():176-185. PubMed ID: 29991446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disulfiram: A novel repurposed drug for cancer therapy.
    Zeng M; Wu B; Wei W; Jiang Z; Li P; Quan Y; Hu X
    Chin Med J (Engl); 2024 Jun; 137(12):1389-1398. PubMed ID: 38275022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach.
    Mettang M; Meyer-Pannwitt V; Karpel-Massler G; Zhou S; Carragher NO; Föhr KJ; Baumann B; Nonnenmacher L; Enzenmüller S; Dahlhaus M; Siegelin MD; Stroh S; Mertens D; Fischer-Posovszky P; Schneider EM; Halatsch ME; Debatin KM; Westhoff MA
    Sci Rep; 2018 Apr; 8(1):5527. PubMed ID: 29615749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
    Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
    Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype.
    Teng J; Hejazi S; Hiddingh L; Carvalho L; de Gooijer MC; Wakimoto H; Barazas M; Tannous M; Chi AS; Noske DP; Wesseling P; Wurdinger T; Batchelor TT; Tannous BA
    Neuro Oncol; 2018 Apr; 20(5):642-654. PubMed ID: 29099956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide.
    Xu X; Zheng Y; Luo L; You Z; Chen H; Wang J; Zhang F; Liu Y; Ke Y
    Cell Death Dis; 2024 May; 15(5):318. PubMed ID: 38710703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.
    Buccarelli M; Marconi M; Pacioni S; De Pascalis I; D'Alessandris QG; Martini M; Ascione B; Malorni W; Larocca LM; Pallini R; Ricci-Vitiani L; Matarrese P
    Cell Death Dis; 2018 Aug; 9(8):841. PubMed ID: 30082680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
    Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.